The results are in! Coming together online and at Rhodes House in Oxford to discuss the findings from the neoGASTRIC trial and what they could mean for neonatal care. A milestone moment for everyone involved in the trial. #neoGASTRIC @npeu-ctu.bsky.social @npeu-oxford.bsky.social

Children under 5 account for around 1 in 3 meningitis deaths worldwide. This #WorldMeningitisDay, join us in raising awareness of meningitis and the research supporting our youngest patients, including studies like BOBBi.
@npeu-ctu.bsky.social @npeu-oxford.bsky.social @oxfordwomenshealth.bsky.social

👶Do you work in a neonatal unit? 👶

Help inform research on respiratory care for babies born at 34–38 weeks. 📝

Take our 3-min survey & share with colleagues!
surveys.npeu.ox.ac.uk/respiratoryc...

@npeu-oxford.bsky.social @oxfordwomenshealth.bsky.social

Was your baby born more than 8 weeks early and had breathing difficulties at birth?
The OPTIMISE trial is looking for parents to help shape new research. No experience needed. Interested?
Email [email protected]
@npeu-oxford.bsky.social @oxfordwomenshealth.bsky.social

Today is #WorldPatientSafetyDay 2026. This year’s theme is “Safe care for noncommunicable diseases” under the slogan “Safe care for life!”

At NPEU, we’re committed to research that helps make care safer for women, babies and families. 💙
#SafeCareForLife

🚨 The OPTIMISE trial is launching!
Run by @npeu-ctu.bsky.social the OPTIMISE trial will recruit 1884 babies and will compare CPAP and NIPPV to find out which is the best way to support very premature babies with breathing difficulties?

Find out more here bit.ly/470kAbo👶

@npeu-oxford.bsky.social

The @bobbistudy.bsky.social receives regulatory approvals!

This is huge milestone for the BOBBi trial! We're delighted to announce that BOBBi has received all the necessary regulatory approvals for the trial to move forward.

👀Read more here: bit.ly/4h5LPHo

@oxfordwomenshealth.bsky.social